肺炎克雷白杆菌感染的表现与治疗方案分析  

Analysis of Klebsiella Pneumoniae Infection and Its Manifestations and Treatment Plan

作　　者：刘建东[1] LIU Jiandong(Xinyi People’s Hospital,Xinyi 525300,China)

机构地区：[1]信宜市人民医院,广东信宜525300

出　　处：《中外医学研究》2018年第19期21-22,共2页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：目的:分析肺炎克雷白杆菌感染的表现,探究不同临床治疗方案的临床效果。方法:研究阶段为2016年6月-2018年1月,共纳入研究对象126例,均为肺炎克雷白杆菌感染患者,根据入院顺序先后分为对照组(n=63)和观察组(n=63),在分析患者临床表现的基础上,对照组采用头孢地嗪治疗,观察组采用头孢哌酮舒巴坦钠联合复方磺胺嘧淀治疗,比较两组临床效果。结果:126例患者大部分临床表现为咳嗽、发热、咳痰、喘息、气促、双肺闻及固定干湿啰音、痰鸣音、胸片有渗出、实变。对照组总有效率为85.71%(54/63),低于观察组的98.41%(62/63),差异有统计学意义(P<0.05)。结论:针对肺炎克雷白杆菌感染患者,会出现咳嗽、发热、咳痰、喘息、气促、双肺闻及固定干湿啰音、痰鸣音、胸片肺纹理增粗临床表现,选择头孢哌酮舒巴坦钠可控制其感染。Objective:To analyze the performance of Klebsiella pneumoniae infection and explore the clinical efficacy of different clinical treatment options.Method:The study period was from June 2016 to January 2018.A total of 126 cases were included in the study.All of them were Klebsiella pneumoniae infection patients.They were divided into control group(n=63)and observation group(n=63)according to the order of admission,in the analysis of clinical manifestations of patients,the control group used Cefodizime treatment,the observation group used Cefoperazone Sulbactam Sodium combined with Compourd Sulfadiazine,the clinical efficacy of the two groups were compared.Result:Most of the 126 patients presented with cough fever,cough,wheezing,shortness of breath,double lungs fixed dry and wet rales,phlegm sounds,chest film effusion,and consolidation.The total effective rate was 85.71%(54/63)in the control group,lower than 98.41%(62/63)in the observation group,the difference was statistically significant(P<0.05).Conclusion:In patients with Klebsiella pneumoniae infection,there may be cough,fever,cough,wheezing,shortness of breath,double lungs fixed dry and wet rales,Phlegm soundslung texture thickening on chest radiographs.Cefoperazone Sulbactam Sodium controls its infection.

关 键 词：肺炎克雷白杆菌 感染 临床表现 治疗 

分 类 号：R446.5[医药卫生—诊断学] R563.1[医药卫生—临床医学]